Zylox-Tonbridge Medical Technology Co (HKSE:02190) Total Liabilities: HK$380 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02190 Zylox-Tonbridge Medical Technology Co Ltd HKSE:02190
82 GF Score
Price HK$19.95
GF Value HK$35.80
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Zylox-Tonbridge Medical Technology Co Total Liabilities?

Zylox-Tonbridge Medical Technology Co HKSE:02190 +3.05% 82 Total Liabilities is HK$380 Mil as of Dec. 2025. GuruFocus rates HKSE:02190 with a GF Score™ of 82/100 and a GF Value™ of HK$35.80 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Zylox-Tonbridge Medical Technology Co's Total Liabilities for the quarter that ended in Dec. 2025 was HK$380 Mil.

Zylox-Tonbridge Medical Technology Co's quarterly Total Liabilities declined from Dec. 2024 (HK$375.35 Mil) to Jun. 2025 (HK$373.79 Mil) but then increased from Jun. 2025 (HK$373.79 Mil) to Dec. 2025 (HK$379.84 Mil).

Zylox-Tonbridge Medical Technology Co's annual Total Liabilities increased from Dec. 2023 (HK$359.11 Mil) to Dec. 2024 (HK$375.35 Mil) and increased from Dec. 2024 (HK$375.35 Mil) to Dec. 2025 (HK$379.84 Mil).

Zylox-Tonbridge Medical Technology Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Zylox-Tonbridge Medical Technology Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zylox-Tonbridge Medical Technology Co Total Liabilities Chart

Zylox-Tonbridge Medical Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 126.87 178.16 359.11 375.35 379.84

Zylox-Tonbridge Medical Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 359.11 405.70 375.35 373.79 379.84
HKSE:02190
82GF Score
Zylox-Tonbridge Medical Technology Co Ltd HKSE:02190
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zylox-Tonbridge Medical Technology Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Zylox-Tonbridge Medical Technology Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=359.851+(1.49+18.5
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=380

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=3947.872-3568.031
=380

Zylox-Tonbridge Medical Technology Co's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=359.851+(1.49+18.5
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=380

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=3947.872-3568.031
=380

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of HK$380 Mil mean?
Zylox-Tonbridge Medical Technology Co (HKSE:02190) has a Total Liabilities of HK$380 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Zylox-Tonbridge Medical Technology Co and its competitors.
Is Zylox-Tonbridge Medical Technology Co's Total Liabilities too high?
Zylox-Tonbridge Medical Technology Co's current Total Liabilities is HK$380 Mil. Overall, Zylox-Tonbridge Medical Technology Co has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zylox-Tonbridge Medical Technology Co's Total Liabilities compare to ABT and SYK?
Zylox-Tonbridge Medical Technology Co's Total Liabilities of HK$380 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Zylox-Tonbridge Medical Technology Co and its competitors. Zylox-Tonbridge Medical Technology Co's current Total Liabilities is HK$380 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zylox-Tonbridge Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Zylox-Tonbridge Medical Technology Co (HKSE:02190) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$35.80, compared to a current price of HK$19.95 — trading 44.3% below its estimated fair value. The current Total Liabilities is HK$380 Mil. Zylox-Tonbridge Medical Technology Co's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Zylox-Tonbridge Medical Technology Co (HKSE:02190), the current Total Liabilities is HK$380 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zylox-Tonbridge Medical Technology Co (HKSE:02190) Overvalued in 2026?

Based on GuruFocus' analysis, Zylox-Tonbridge Medical Technology Co stock appears to be undervalued. The current stock price of HK$19.95 is trading 44.3% below its estimated GF Value™ of HK$35.80. GuruFocus considers Zylox-Tonbridge Medical Technology Co to be Significantly Undervalued.

Key valuation signals for HKSE:02190:

  • Total Liabilities: HK$380 Mil
  • GF Value™: HK$35.80 vs. price of HK$19.95 (44.3% below fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the HKSE:02190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zylox-Tonbridge Medical Technology Co Business Description

Other Exchanges 818:Germany
Address 270 Shuyun Road, Cangqian Street, Zylox-Tonbridge Industrial Park, Yuhang District, Zhejiang Province, Hangzhou, CHN
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's products include Thrombite Clot Retriever Device (Thrombite CRD), Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB), and others. The company derives majority of its revenue from PRC.
82GF Score

Get the complete analysis for HKSE:02190

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$19.95
Price
HK$35.80
GF Value